127 related articles for article (PubMed ID: 6979565)
1. Purification and partial characterization of a C1q inhibitor from the membranes of human peripheral blood lymphocytes.
Ghebrehiwet B; Hamburger M
J Immunol; 1982 Jul; 129(1):157-62. PubMed ID: 6979565
[No Abstract] [Full Text] [Related]
2. Stoichiometry and sedimentation properties of the complex formed between the C1q and C1r2C1s2 subcomponents of the first component of complement.
Siegel RC; Schumaker VN; Poon PH
J Immunol; 1981 Dec; 127(6):2447-52. PubMed ID: 6975324
[TBL] [Abstract][Full Text] [Related]
3. C1q inhibitor (C1qINH): functional properties and possible relationship to a lymphocyte membrane-associated C1q precipitin.
Ghebrehiwet B
J Immunol; 1981 May; 126(5):1837-42. PubMed ID: 7217670
[No Abstract] [Full Text] [Related]
4. Low molecular weight C1q-precipitins in hypocomplementemic vasculitis-urticaria syndrome: partial purification and characterization as immunoglobulin.
Marder RJ; Burch FX; Schmid FR; Zeiss CR; Gewurz H
J Immunol; 1978 Aug; 121(2):613-8. PubMed ID: 28369
[TBL] [Abstract][Full Text] [Related]
5. Active disassembly of the first complement component, C-1, by C-1 inactivator.
Ziccardi RJ; Cooper NR
J Immunol; 1979 Aug; 123(2):788-92. PubMed ID: 110880
[No Abstract] [Full Text] [Related]
6. Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. Purification and immunochemical characterization.
Ghebrehiwet B; Silvestri L; McDevitt C
J Exp Med; 1984 Nov; 160(5):1375-89. PubMed ID: 6436431
[TBL] [Abstract][Full Text] [Related]
7. Partial purification and some properties of a plasma inhibitor of activated plasma thromboplastin antecedent (factor XI).
Amir J; Ratnoff OD; Pensky J
J Lab Clin Med; 1972 Dec; 80(6):786-802. PubMed ID: 4673715
[No Abstract] [Full Text] [Related]
8. Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum.
Tamura N; Nelson RA
J Immunol; 1967 Sep; 99(3):582-9. PubMed ID: 6051385
[No Abstract] [Full Text] [Related]
9. Antisera to erythropoietin: partial characterization of two different antibodies.
Lange RD; McDonald TP; Jordan T
J Lab Clin Med; 1969 Jan; 73(1):78-90. PubMed ID: 5762167
[No Abstract] [Full Text] [Related]
10. A complete selective C1q deficiency in a patient with discoid lupus erythematosus (DLE).
Uenaka A; Akimoto T; Aoki T; Tsuyuguchi I; Nagaki K
Clin Exp Immunol; 1982 May; 48(2):353-8. PubMed ID: 6980744
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
[TBL] [Abstract][Full Text] [Related]
12. Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1.
Kirschfink M; Blase L; Engelmann S; Schwartz-Albiez R
J Immunol; 1997 Feb; 158(3):1324-31. PubMed ID: 9013976
[TBL] [Abstract][Full Text] [Related]
13. C1q inhibitor (chondroitin-4-sulfate proteoglycan): structure and function.
Ghebrehiwet B; Galanakis DK
Behring Inst Mitt; 1993 Dec; (93):214-23. PubMed ID: 8172570
[TBL] [Abstract][Full Text] [Related]
14. Human T cell leukemia antigens on the cell membranes: purification molecular characterization, and preparation of specific antisera.
Seon BK; Negoro S; Minowada J; Yoshizaki K
J Immunol; 1981 Dec; 127(6):2580-8. PubMed ID: 6975329
[No Abstract] [Full Text] [Related]
15. The first component of complement. I. Purification and properties of native C1.
Medicus RG; Chapuis RM
J Immunol; 1980 Jul; 125(1):390-5. PubMed ID: 7381205
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional studies in C1q deficiency.
Chapuis RM; Hauptmann G; Grosshans E; Isliker H
J Immunol; 1982 Oct; 129(4):1509-12. PubMed ID: 6980939
[TBL] [Abstract][Full Text] [Related]
17. The third component of the guinea pig complement system. I. Purification and characterization.
Shin HS; Mayer MM
Biochemistry; 1968 Aug; 7(8):2991-6. PubMed ID: 5666765
[No Abstract] [Full Text] [Related]
18. Purification and characterization of human, guinea pig and mouse C1q by fast protein liquid chromatography (FPLC).
Stemmer F; Loos M
J Immunol Methods; 1984 Nov; 74(1):9-16. PubMed ID: 6334116
[TBL] [Abstract][Full Text] [Related]
19. Separation of C'4 from C'1 inactivator and purification of both substances.
Inai S; Hiramatsu S; Nagaki K
Biken J; 1967 Sep; 10(3):155-74. PubMed ID: 4170106
[No Abstract] [Full Text] [Related]
20. Purification and properties of a lymphocyte inhibition factor from human serum.
Ford WH; Caspary EA; Shenton B
Clin Exp Immunol; 1973 Oct; 15(2):169-79. PubMed ID: 4762015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
